Friday, 27 October 2017

Therapeutic Drug Monitoring Market by Product & Class of Drug — 2020

T”he technological advances in tests used to monitor therapeutic drugs, increased knowledge of pharmacogenetics and pharmacokinetics of drugs, need for better healthcare in developing countries, and rising prevalence of psychiatric diseases and cancer are the major drivers for the Therapeutic Drug Monitoring market”.

Adjunct technologies such as biomarker identification using proteomics to accurately identify clinical outcome and genetic testing are expected to benefit the growth of the therapeutic drug monitoring market. However, high infrastructure costs and dearth of skilled resources may restraint the Therapeutic Drug Monitoring market growth.

On the basis of technology : 

The therapeutic drug monitoring market is categorized into three segments namely, immunoassays, proteomic technologies and others. The immunoassays segment is expected to account for the largest share of its technology market in 2015. Factors such as relatively simple tests and requirement of minimal training to handle the immunoassay analyzers will drive the growth of this segment.

On the basis of class of drug :

The therapeutic drug monitoring market is segmented into antiepileptics, antibiotics, immunosuppressants, antiarrhythmic drugs, bronchodilators, psychoactive drugs, and others classes. The antiepileptics segment is estimated to account for the largest share in 2015. By end user, the market is divided into hospital labs, commercial/private labs, and other end users. The hospital labs segment is estimated to account for the largest share in 2015.

Regional Analysis : 

North America is expected to account for more than half the therapeutic drug monitoring market share in 2015. It is the prime market for therapeutics drug monitoring due to the high awareness and acceptance of the benefits of therapeutic drug monitoring and growing healthcare expenditure. 
                                         Therapeutic Drug Monitoring Market

The Therapeutic Drug Monitoring market in Europe on the other hand is growing at a slower rate as the healthcare sector is recovering from the economic downturn and the healthcare facilities are trying to minimize healthcare delivery costs. Growth in the APAC therapeutic drug monitoring market is comparatively slower due to the dearth of skilled healthcare personnel for performing therapeutic drug monitoring tests with minimal errors.

Prominent Players : 

Players in the therapeutic drug monitoring market include F. Hoffmann-La Roche AG (Switzerland), Siemens Healthcare (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Danaher Corporation (U.S.).

For Press Release : 

No comments:

Post a Comment